www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

Grant of share options to members of the Board of Management and senior managers

November 19, 2009

PDF Version

Supporting Materials:
fm-16-09-uk.pdf
According to the guidelines for incentive pay adopted by the annual general
meeting, the Board of Directors has passed a resolution to grant share options.
A total of 59,000 share options will be granted, comprising 23,600 options to
the members of the Board of Management and 35,400 options to a group of senior
managers. 

The options can be exercised during the period from November 1, 2012 to
November 1, 2016 during the four-week trading windows following the release of
annual and interim reports. If the option holders have not exercised their
options within the period specified, the options will lapse without any
compensation to the holders. 

The exercise price of the options has been set at DKK 465 each, corresponding
to an average of the closing prices of the company's shares on the NASDAQ OMX
Copenhagen A/S during the period November 12 - November 18, 2008 (both days
included). To this should be added annual interest at the rate of 2.5%, which
will be added the first time on November 1, 2010. The exercise price of the
options will be adjusted on payment of dividend, to the effect that DKK 1 of
dividend per share results in a reduction of the exercise price by DKK 1. 

The market value of the adopted option plan of 59,000 options is DKK 10.2
million applying the Black & Scholes model for valuation of options. The
determination of the value is based on an assumed exercise price of DKK 513, an
annual dividend distribution of DKK 5 per share, a volatility rate of 45% p.a.
and a risk-free interest rate of 3.6% p.a. 

Under the international financial reporting standards (IFRS), the option plan
will be recognized in the income statement in the respective functional areas
over the vesting period. 

The grant of share options does not change the company's financial forecast. 

No share options have been granted to members of the Board of Directors.

ALK-Abelló A/S


Jørgen Worning
Chairman

Contact person: Jørgen Worning, Chairman of the Board of Directors, 
tel +45 4576 7405
  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved